SALT LAKE CITY –– Remedy Informatics, the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced today that Scott C. Howard, MD, MSc, will join the company’s executive team as Chief Medical Officer (CMO). Dr. Howard comes to Remedy from St. Jude Children’s Research Hospital where he was a […]
France — The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent directors, Agnès Lemarchand and Philippe Gillet. Agnès Lemarchand and Philippe Gillet were appointed to replace Georges Hibon and Michel Angé, who did not wish to renew their terms […]
OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications. BSI is currently one of the world’s largest independent certification bodies for quality management systems and ISO 13485:2003 is […]
MENLO PARK, Calif. & ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Asterias Biotherapeutics, Inc. (“Asterias”), announced that Asterias has entered into a settlement agreement with ViaCyte, Inc. (“ViaCyte”) concerning certain litigation in the United States District Court for the Northern District of California (Civil Action No. C12-04813) seeking the reversal of two […]
CINCINNATI — Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received medical device license approval from Health Canada to market two additional assays for use on their illumigene® molecular diagnostic platform. With the addition of illumigene Mycoplasma and illumigene Pertussis, Meridian continues to expand its position in the Canadian market by […]
GERMANTOWN, Maryland, and HILDEN, Germany – — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its therascreen® KRAS RGQ PCR Kit (therascreen KRAS test) has received U.S. Food and Drug Administration (FDA) approval to guide the treatment of metastatic colorectal cancer patients with Amgen’s Vectibix® (panitumumab). This marks the third FDA approval […]
PerkinElmer to Serve as Exclusive Global Distributor for Sebia’s Hemoglobin Newborn Screening System
PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, today announced an agreement to become the exclusive global distributor for Sebia’s CAPILLARYS™ 2 NEONAT FAST offering to newborn screening laboratories. This system enables fully automated hemoglobin newborn screening from dried blood spot samples by capillary electrophoresis. This year, […]
Alameda, CA.–– Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMCTM) technology for clinical diagnostics and scientific discovery, today announced the appointment of Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer. At Singulex, Dr. Heseltine will have overall responsibility for clinical strategy, including scientific and medical affairs. “Peter brings a wealth […]
LEXINGTON, Mass.-– N-of-One, the leading provider of clinical interpretation for precision medicine in oncology, today announced an agreement with Mayo Clinic to provide access to clinical interpretation information to aid in highly complex molecular diagnostics. Under the terms of the agreement, in select cases, N-of-One solutions will assist in the identification of biological and clinical […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
